Asset Entities ASST Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Asset Management | $1.35M-9.9% | $1.5M-64.4% | $4.19M+195% | $1.42M+37.5% | $1.04M+5.2% | |
| Corporate & Other | $43K+153% | $17K-39.3% | $28K— | $0— | $0— | |
| Medical Device | $1.37M— | —— | —— | $0— | —— | |
| Net loss by Business | ||||||
| Asset Management | -$2M+66.3% | -$5.94M+19.4% | -$7.37M-96.6% | -$3.75M+9.0% | -$4.12M+39.5% | |
| Corporate & Other | -$258M+33.4% | -$387.66M-1,876% | -$19.62M— | $0— | $0— | |
| Medical Device | -$5.91M— | —— | —— | $0— | —— | |
| Other Operating Income by Business | ||||||
| Asset Management | $0— | $0— | $0— | $0— | $0— | |
| Corporate & Other | -$295.29M-41.1% | -$209.24M— | $0— | $0— | $0— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Nonoperating Income (Expense) by Business | ||||||
| Asset Management | $11K-26.7% | $15K-95.8% | $360K+11.1% | $324K-43.6% | $574K+176% | |
| Corporate & Other | $47.03M+131% | -$152.48M-884% | -$15.49M— | $0— | $0— | |
| Medical Device | $205K— | —— | —— | $0— | —— | |
| Other income by Business | ||||||
| Asset Management | $11K-26.7% | $15K-95.8% | $360K+11.1% | $324K+9.8% | $295K+41.8% | |
| Corporate & Other | $310K-56.2% | $708K+213% | $226K— | $0— | $0— | |
| Medical Device | $205K— | —— | —— | $0— | —— | |
| Operating Income (Loss) by Business | ||||||
| Asset Management | -$2.01M+66.2% | -$5.95M+23.0% | -$7.73M-89.8% | -$4.07M+13.2% | -$4.69M+33.1% | |
| Corporate & Other | -$305.03M-29.7% | -$235.18M-5,594% | -$4.13M— | $0— | $0— | |
| Medical Device | -$6.11M— | —— | —— | $0— | —— | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest by Business | ||||||
| Asset Management | -$2M+66.3% | -$5.94M+19.4% | -$7.37M-96.6% | -$3.75M+9.0% | -$4.12M+39.5% | |
| Corporate & Other | -$258M+33.4% | -$387.66M-1,876% | -$19.62M— | $0— | $0— | |
| Medical Device | -$5.91M— | —— | —— | $0— | —— | |
| Income tax expense (benefit) by Business | ||||||
| Asset Management | $0— | $0— | $0— | $0— | $0— | |
| Corporate & Other | $0— | $0— | $0— | $0— | $0— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Total Assets by Business | ||||||
| Asset Management | $1.28M+0.4% | $1.28M-13.1% | $1.47M— | —— | $28.2M— | |
| Corporate & Other | $1.08B+45.3% | $744.25M-5.9% | $791.11M— | —— | $0— | |
| Medical Device | $17.63M— | $0— | —— | —— | —— | |
| Operating Expenses by Business | ||||||
| Asset Management | $3.36M-54.9% | $7.45M-37.5% | $11.92M+117% | $5.5M-4.0% | $5.73M-28.4% | |
| Corporate & Other | $9.78M-62.3% | $25.96M+524% | $4.16M— | $0— | $0— | |
| Medical Device | $7.48M— | —— | —— | $0— | —— | |
| Interest Expense, Long-Term Debt by Business | ||||||
| Asset Management | $0— | —— | —— | $0— | —— | |
| Corporate & Other | $242K— | —— | —— | $0— | —— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Marketing and advertising by Business | ||||||
| Asset Management | $7K-63.2% | $19K-78.4% | $88K+44.3% | $61K-85.4% | $419K+371% | |
| Corporate & Other | $109K-17.4% | $132K-7.7% | $143K— | $0— | $0— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| General and administrative expense by Business | ||||||
| Asset Management | $637K+1.0% | $631K-76.4% | $2.67M+40.2% | $1.91M+57.8% | $1.21M-72.6% | |
| Corporate & Other | $3.03M-0.6% | $3.05M+95.9% | $1.56M— | $0— | $0— | |
| Medical Device | $2.27M— | —— | —— | $0— | —— | |
| Change in fair value by Business | ||||||
| Asset Management | $0— | $0— | $0— | $0— | $0— | |
| Corporate & Other | $490K+100% | -$194.51M— | $0— | $0— | $0— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Employee compensation and benefits by Business | ||||||
| Asset Management | $1.29M-73.8% | $4.93M+1.5% | $4.86M+135% | $2.07M-22.6% | $2.67M+22.4% | |
| Corporate & Other | $6.58M-71.0% | $22.71M+862% | $2.36M— | $0— | $0— | |
| Medical Device | $5.18M— | —— | —— | $0— | —— | |
| Loss on Debt Extinguishment by Business | ||||||
| Asset Management | $0— | —— | —— | $0— | —— | |
| Corporate & Other | -$8.46M— | —— | —— | $0— | —— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| D&A by Business | ||||||
| Asset Management | $0— | $0-100% | $52K0.0% | $52K+2.0% | $51K+8.5% | |
| Corporate & Other | $58K-18.3% | $71K-26.8% | $97K— | $0— | $0— | |
| Medical Device | $32K— | —— | —— | $0— | —— | |
| Bargain purchase gain by Business | ||||||
| Asset Management | $0— | —— | —— | $0— | —— | |
| Corporate & Other | $66.7M— | —— | —— | $0— | —— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Transaction costs by Business | ||||||
| Asset Management | $0— | $0— | $0— | $0— | $0— | |
| Corporate & Other | $6.53M-47.4% | $12.4M-21.1% | $15.72M— | $0— | $0— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Change in fair value on long-term notes payable, at fair value by Business | ||||||
| Asset Management | $0— | —— | —— | $0— | —— | |
| Corporate & Other | -$2.17M— | —— | —— | $0— | —— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Fund management and administration by Business | ||||||
| Asset Management | $1.42M-23.7% | $1.87M-56.1% | $4.25M+201% | $1.41M+2.3% | $1.38M+8.4% | |
| Corporate & Other | $0— | $0— | $0— | $0— | $0— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Loss on change in fair value of bitcoin held as collateral under Coinbase Loan by Business | ||||||
| Asset Management | $0— | —— | —— | $0— | —— | |
| Corporate & Other | -$2.59M— | —— | —— | $0— | —— | |
| Medical Device | $0— | —— | —— | $0— | —— | |
| Total revenues by Product | ||||||
| Investment advisory fees | $1.35M-9.9% | $1.5M-64.3% | $4.19M+196% | $1.42M+37.2% | $1.03M+8.6% | |
| Medical device revenues | $1.37M— | —— | —— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Asset Entities break its business down?
- Asset Entities (ASST) reports total revenues by business across 3 parts — Asset Management, Corporate & Other and Medical Device. Each is extracted from the segment footnotes and tracked over time.
- Where does Asset Entities's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Asset Entities's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
